GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...

In combination with pembrolizumab, for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). In combination with everolimus, for the treatment of adult patients with ...

Formula 1 has long been more than a sport. For leading car manufacturers, it functions as a high-speed research and ...

Tradeweb Markets Inc. , a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today reported financial results for the quarter ended September 30, 2025.

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.

By electrically stimulating macrophages, scientists at Trinity College Dublin have found a way to calm inflammation and ...

A cell’s “death fold domain” protects our bodies from infection at the risk of chronic inflammation, essentially “trading ...

Scientists have already created designer viruses in a lab that can kill dangerous bacteria. The next step is designing and ...

The NEURL E3 ubiquitin ligases selectively activate the Notch ligands DLL1 and JAG1, but not DLL4 and JAG2. This differential ...

Merck and Eisai Announce WELIREG® Plus LENVIMA® Met Primary Endpoint of PFS in Certain Previously Treated Patients With ...